Human immunodeficiency virus causes mononuclear phagocyte dysfunction.
There is compelling clinical evidence for dysfunction of the mononuclear phagocyte system in patients with AIDS, which is believed due in part to loss of T-cell cooperativity. The direct consequences of human immunodeficiency virus infection on macrophage function are unknown. To address this question we infected normal human macrophages in vitro with a monocytotropic strain of human immunodeficiency virus and performed assays to quantify their extra- and intracellular killing ability. Human immunodeficiency virus-infected macrophages were significantly less effective than control cells in mediating antibody-dependent cell-mediated cytotoxicity against leukemic cell targets and intracellular killing of Candida pseudotropicalis. The functional defects were profound, related temporarily to active virus production by the macrophages, and could not be overcome by granulocyte-macrophage colony-stimulating factor. Treatment of macrophages with 3'-azido-3'-deoxythymidine (AZT) 6 days after infection caused a marked decrease in virus production and prevented development of the intracellular killing functional defect. The results suggest that early antiviral therapy may be useful in preventing or mitigating some virus-induced mononuclear phagocyte dysfunction.
Division of Hematology-Oncology, UCLA School of Medicine 90024.
G C
GC
Baldwin
J
J
Fleischmann
Y
Y
Chung
Y
Y
Koyanagi
I S
IS
Chen
D W
DW
Golde
D000920:Antibody-Dependent Cell Cytotoxicity; D002478:Cells, Cultured; D003115:Colony-Stimulating Factors / Q000494:pharmacology; D004731:Endotoxins / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000494:pharmacology; D006678:HIV / Q000276:immunology*; D006801:Humans; D007700:Kinetics; D008264:Macrophages / Q000276:immunology* / Q000382:microbiology; D009000:Monocytes / Q000187:drug effects / Q000276:immunology* / Q000382:microbiology
D003115:Colony-Stimulating Factors; D004731:Endotoxins; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor